A randomized, double-blind, multi-center, active-control, parallel group study to compare efficacy, safety, immunogenicity and pharmacokinetics of Lupin’s Nivolumab (LUBT022) with Innovator’s Nivolumab in patients with locally advanced or metastatic non-small cell lung cancer.
Take the first step towards hope and healing – book your appointment with Shashwat Hospitals today!
Shashwat Hospitals is a leading oncology hospital in the Saurashtra region, dedicated to providing comprehensive, compassionate, and patient-centric cancer care with a commitment to clinical excellence and innovation.